Cardiac transplantation

Insights

Orthotopic cardiac transplantation is a viable treatment for end-stage heart disease, offering high survival and rehabilitation rates. Advances in immunosuppression are key to improving long-term outcomes for heart transplant patients.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Immunology

Background:

  • End-stage heart disease (EHD) significantly impacts patient prognosis.
  • Inoperable EHD necessitates advanced therapeutic interventions.
  • Cardiac transplantation is a potential solution for select EHD patients.

Purpose of the Study:

  • To evaluate orthotopic cardiac transplantation as a treatment for inoperable end-stage heart disease.
  • To assess survival and rehabilitation outcomes following cardiac transplantation.
  • To identify factors influencing survival rates in heart transplant recipients.

Main Methods:

  • Retrospective analysis of 188 patients undergoing orthotopic cardiac transplantation at Stanford.
  • Comparison of survival rates with cadaver renal transplant series.
  • Assessment of patient rehabilitation potential.

Main Results:

  • Orthotopic cardiac transplantation is a reasonable therapeutic option for patients with inoperable end-stage heart disease.
  • Survival expectations are comparable to cadaver renal transplantation.
  • Rehabilitation potential exceeds 90% for eligible patients.

Conclusions:

  • Cardiac transplantation offers significant benefits for patients with inoperable end-stage heart disease.
  • Current survival limitations are primarily linked to immunosuppression strategies.
  • Future advancements in immunosuppression are expected to enhance cardiac transplant outcomes.

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...